Back to Search
Start Over
LATEST COMPANY NEWS
- Source :
- United Kingdom Pharmaceuticals. January 7, 2025
- Publication Year :
- 2025
-
Abstract
- PharmaTimes - Amgen's lung cancer treatment gets conditional approval - 6/1/2025 The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for IMDYLLTRA (tarlatamab), a [...]
- Subjects :
- Pfizer Inc.
GSK PLC
Roche Holding (UK) Ltd.
Seagen Inc.
AstraZeneca PLC
Eli Lilly and Co.
United States. Food and Drug Administration
Association of the British Pharmaceutical Industry
European Union
Nucala (Medication)
Verzenio (Medication)
Mounjaro (Medication)
Yervoy (Medication)
Paxlovid (Medication)
Opdivo (Medication)
Zepbound (Medication)
Breyanzi (Medication)
Care and treatment
Cancer treatment
Lung cancer -- Care and treatment
Blinatumomab
Nivolumab
Respiratory system agents
Anti-obesity agents
Evolocumab
Independent regulatory commissions
Drug approval
Weight loss -- Care and treatment
Semaglutide
Respiratory agents
Cancer -- Care and treatment
Weight reducing preparations
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- United Kingdom Pharmaceuticals
- Publication Type :
- News
- Accession number :
- edsgcl.822708086